144 related articles for article (PubMed ID: 31986423)
1. Tributyltin(IV) ferulate, a novel synthetic ferulic acid derivative, induces autophagic cell death in colon cancer cells: From chemical synthesis to biochemical effects.
Pellerito C; Emanuele S; Ferrante F; Celesia A; Giuliano M; Fiore T
J Inorg Biochem; 2020 Apr; 205():110999. PubMed ID: 31986423
[TBL] [Abstract][Full Text] [Related]
2. ROS-Dependent ER Stress and Autophagy Mediate the Anti-Tumor Effects of Tributyltin (IV) Ferulate in Colon Cancer Cells.
Celesia A; Morana O; Fiore T; Pellerito C; D'Anneo A; Lauricella M; Carlisi D; De Blasio A; Calvaruso G; Giuliano M; Emanuele S
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143349
[TBL] [Abstract][Full Text] [Related]
3. Tributyltin(IV) Butyrate: A Novel Epigenetic Modifier with ER Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells.
Giuliano M; Pellerito C; Celesia A; Fiore T; Emanuele S
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443600
[TBL] [Abstract][Full Text] [Related]
4. Sicilian Litchi Fruit Extracts Induce Autophagy versus Apoptosis Switch in Human Colon Cancer Cells.
Emanuele S; Notaro A; Palumbo Piccionello A; Maggio A; Lauricella M; D'Anneo A; Cernigliaro C; Calvaruso G; Giuliano M
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30322062
[No Abstract] [Full Text] [Related]
5. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.
Pellerito O; Notaro A; Sabella S; De Blasio A; Vento R; Calvaruso G; Giuliano M
Apoptosis; 2014 Jun; 19(6):1029-42. PubMed ID: 24696378
[TBL] [Abstract][Full Text] [Related]
6. Physalin B not only inhibits the ubiquitin-proteasome pathway but also induces incomplete autophagic response in human colon cancer cells in vitro.
Ma YM; Han W; Li J; Hu LH; Zhou YB
Acta Pharmacol Sin; 2015 Apr; 36(4):517-27. PubMed ID: 25832431
[TBL] [Abstract][Full Text] [Related]
7. A novel cycloartane triterpenoid from Cimicifuga induces apoptotic and autophagic cell death in human colon cancer HT-29 cells.
Dai X; Liu J; Nian Y; Qiu MH; Luo Y; Zhang J
Oncol Rep; 2017 Apr; 37(4):2079-2086. PubMed ID: 28260002
[TBL] [Abstract][Full Text] [Related]
8. Koelreuteria Formosana Extract Induces Growth Inhibition and Cell Death in Human Colon Carcinoma Cells via G2/M Arrest and LC3-II Activation-Dependent Autophagy.
Horng CT; Wu YJ; Chen PN; Chu SC; Tsai CM; Hsieh YS
Nutr Cancer; 2017 Jan; 69(1):44-55. PubMed ID: 27880045
[TBL] [Abstract][Full Text] [Related]
9. A surface-layer protein from Lactobacillus acidophilus NCFM induces autophagic death in HCT116 cells requiring ROS-mediated modulation of mTOR and JNK signaling pathways.
Wang H; Cheng X; Zhang L; Xu S; Zhang Q; Lu R
Food Funct; 2019 Jul; 10(7):4102-4112. PubMed ID: 31233063
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of autophagy enhances DENSpm-induced apoptosis in human colon cancer cells in a p53 independent manner.
Gurkan AC; Arisan ED; Yerlikaya PO; Ilhan H; Unsal NP
Cell Oncol (Dordr); 2018 Jun; 41(3):297-317. PubMed ID: 29492901
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic, Antiproliferative and Apoptotic Effects of Phenolic Acids in Human Colon Adenocarcinoma Cells Using In Vitro and In Silico Approaches.
Rosa LS; Jordão NA; da Costa Pereira Soares N; deMesquita JF; Monteiro M; Teodoro AJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30297681
[TBL] [Abstract][Full Text] [Related]
12. BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.
Goulielmaki M; Koustas E; Moysidou E; Vlassi M; Sasazuki T; Shirasawa S; Zografos G; Oikonomou E; Pintzas A
Oncotarget; 2016 Feb; 7(8):9188-221. PubMed ID: 26802026
[TBL] [Abstract][Full Text] [Related]
13. Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma.
Pal I; Parida S; Prashanth Kumar BN; Banik P; Kumar Dey K; Chakraborty S; Bhutia SK; Mandal M
Eur J Pharmacol; 2015 Oct; 765():217-27. PubMed ID: 26306675
[TBL] [Abstract][Full Text] [Related]
14. The novel anthraquinone derivative IMP1338 induces death of human cancer cells by p53-independent S and G2/M cell cycle arrest.
Choi HK; Ryu H; Son AR; Seo B; Hwang SG; Song JY; Ahn J
Biomed Pharmacother; 2016 Apr; 79():308-14. PubMed ID: 27044842
[TBL] [Abstract][Full Text] [Related]
15. Tributyltin induces G2/M cell cycle arrest via NAD(+)-dependent isocitrate dehydrogenase in human embryonic carcinoma cells.
Asanagi M; Yamada S; Hirata N; Itagaki H; Kotake Y; Sekino Y; Kanda Y
J Toxicol Sci; 2016 Apr; 41(2):207-15. PubMed ID: 26961604
[TBL] [Abstract][Full Text] [Related]
16. Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells.
Serafim TL; Carvalho FS; Marques MP; Calheiros R; Silva T; Garrido J; Milhazes N; Borges F; Roleira F; Silva ET; Holy J; Oliveira PJ
Chem Res Toxicol; 2011 May; 24(5):763-74. PubMed ID: 21504213
[TBL] [Abstract][Full Text] [Related]
17. Sodium 5,6-benzylidene-L-ascorbate induces oxidative stress, autophagy, and growth arrest in human colon cancer HT-29 cells.
Cheung FW; Che CT; Sakagami H; Kochi M; Liu WK
J Cell Biochem; 2010 Oct; 111(2):412-24. PubMed ID: 20503249
[TBL] [Abstract][Full Text] [Related]
18. Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents.
Stefanizzi V; Minutolo A; Valletta E; Carlini M; Cordero FM; Ranzenigo A; Prete SP; Cicero DO; Pitti E; Petrella G; Matteucci C; Marino-Merlo F; Mastino A; Macchi B
Molecules; 2023 May; 28(9):. PubMed ID: 37175265
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
Kim DH; Kim MJ; Sung B; Suh H; Jung JH; Chung HY; Kim ND
Oncol Rep; 2017 Jan; 37(1):281-288. PubMed ID: 27840966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
